A carregar...
Emerging Perspectives on mTOR Inhibitor‐Associated Pneumonitis in Breast Cancer
Substantial improvements in the early detection and treatment of breast cancer have led to improvements in survival, but breast cancer remains a significant cause of morbidity and mortality in women. In 2012, the mammalian target of rapamycin (mTOR) inhibitor everolimus was approved by the U.S. Food...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6067931/ https://ncbi.nlm.nih.gov/pubmed/29487226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0343 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|